Purified anti-Oct-1 POU2F1 Antibody, Oct-1, W18054D,BioLegend,625701

This clone was not tested for ICCNon-specific band present in Ramos at 60 kD

Host

Rat

Reactivity

Human, Mouse

Application

WB -Quality testedIP -Verified

Platform ID

BAB331052956

BioLegend

Headquarters

8999 BioLegend Way San Diego, CA 92121 United States

Contact

Tel: 1-858-455-9588
Fax: +49 (4131) 7023913

Email:

Product Specifications
Scientific Background

Specifications

NamePurified anti-Oct-1 POU2F1 Antibody, Oct-1, W18054D
Cat. No.625701
HostRat
RRIDAB_2814492 (BioLegend Cat. No. 625701)AB_2814493 (BioLegend Cat. No. 625702)
IsotypeRat IgG2a, κ
ReactivityHuman, Mouse
ApplicationWB -Quality testedIP -Verified
ClonalityMonoclonal
Clone NumberW18054D
Concentration0.5 mg/ml
Target1-Oct
ImmunogenPartial recombinant protein corresponding to human OCT-1 amino acid residues 251-500
PurityThe antibody was purified by affinity chromatography.
FormulationPhosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
StorageThe antibody solution should be stored undiluted between 2°C and 8°C.
Regulatory StatusResearch Use Only

Scientific Background

Oct-1 is a member of the Pit-Oct-Unc (POU) domain family of transcription factors, which are characterized by a bipartite POU domain. The POU domain that contains two DNA-binding subdomains; an N-terminal POU-specific subdomain and a C-terminal homeobox subdomain, each of which are tethered by a variable linker sequence. Oct-1 can function as both a transcriptional activator and repressor, and controls the expression of housekeeping genes such as those encoding Histone H2B and snRNPs, as well as genes involved in development and differentiation. The highly-modular POU domain enables Oct-1 to drive diverse transcriptional programming that occurs in a tissue-specific manner. The POU domains confers the flexibility for Oct-1 to function as both a monomer, dimer, and heterodimer, and also facilitates the interaction between Oct-1 with a broad set of transcriptional cofactor proteins. Moreover, Oct-1 undergoes multiple post-translational modifications that confers DNA-binding specificity to certain promoters, including phosphorylation, ubiquitination, and sumoylation. Oct-1 is highly-expressed in many types of cancers, and functionally different isoforms produced from alternative promoter usage have been reported.

Category Paths

Request a product

Please provide the required information below so that we can quickly source your products.